← Back to Search

Supine MRI for Breast Cancer

N/A
Waitlist Available
Led By Tari King, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after surgery
Awards & highlights

Study Summary

This study is evaluating whether a common imaging test may help surgeons decide whether to perform a mastectomy or lumpectomy.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time between supine breast mri imaging and surgery; median 25.5 days, range 11-40 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and time between supine breast mri imaging and surgery; median 25.5 days, range 11-40 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correlation Between Prone Breast MRI for Estimation of Tumor Size and Final Pathology Tumor Size
Correlation Between Supine Breast MRI for Estimation Of Tumor Size and The Pathologic Tumor Size
Correlation of Breast Tumor Dimensions Between Prone and Supine Imaging Positions.
Secondary outcome measures
The Perceived Benefit Of Supine MRI For Surgical Planning As Measured By The Collective Results Of A Survey Of Surgeons Performing Breast-conserving Therapy (BCT) In Our Study Patient Population

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supine MRIExperimental Treatment6 Interventions
Standard MRI will be performed Supine MRI will be performed Participant will receive mammography and ultrasound Breast Radiologist will take a brief survey. Patients will undergo upfront surgery or receive Neoadjuvant Therapy per standard of care Standard of care will be performed
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard MRI
2016
N/A
~60
Supine MRI
2016
N/A
~220
Ultrasound
2013
Completed Phase 1
~1950
Mammography
2015
N/A
~1450
Standard of Care
2017
Completed Phase 4
~4420

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,078 Previous Clinical Trials
340,815 Total Patients Enrolled
141 Trials studying Breast Cancer
22,560 Patients Enrolled for Breast Cancer
Tari King, MD4.26 ReviewsPrincipal Investigator - Brigham and Women's Hospital
Dana-Farber Cancer Institute
2 Previous Clinical Trials
165 Total Patients Enrolled
1 Trials studying Breast Cancer
45 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy
Tari King, MD 2016. "Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02956473.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top